← FDA Drug Approvals (Drugs@FDA)

SIROLIMUS

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2019-10-22

Drug application

FDA Application #

ANDA211406

Application type

Abbreviated New Drug Application (Generic)

Brand name

SIROLIMUS

Generic name

SIROLIMUS

Active ingredients

SIROLIMUS

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

APOTEX

Manufacturer

Apotex Corp

First approval

2019-10-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown